Dr. Carol M. Mathew, MD

Dr. Mathew practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Mathew's NPI, 1104265438, was assigned on June 20, 2013. Dr. Mathew graduated from Ross University School of Medicine in 2013. Dr. Mathew holds Florida license ME146143.

Dr. Mathew's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Mathew's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. Dr. Mathew is also affiliated with UF Health Spanish Plaines Hospital. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathew practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mathew's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mathew is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mathew's licenses on file in 2 states: Florida and Massachusetts.

Dmand AI lists chronic anemia, deep vein thrombosis (DVT), lymphoma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Mathew treats.

CMS data shows 1,005 Medicare services from Dr. Mathew across 10 procedure codes in 2024, for 452 Medicare patients. Medicare paid $60,713 for them.

CMS counts 452 Medicare patients who saw Dr. Mathew in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mathew's median patient age at 72, with 63% women.

In 2024, Dr. Mathew wrote 364 Medicare Part D claims for 91 patients. 68% of them were for generic drugs. CMS names the drug for 271 of them, across 7 drugs with 11 or more claims each, at $94,886 in total drug cost. In 2023, CMS named 252 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Mathew for performance year 2024, reported through an alternative payment model (APM). Dr. Mathew accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mathew as offering telehealth.

Dmand AI links 8 papers to Dr. Mathew, published from 2018 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Thrombosis and Anticoagulants. Dr. Mathew has published most often in Hematology Am Soc Hematol Educ Program. Dr. Mathew's most frequent co-authors are Marc Stuart Zumberg, MD, Venu Gopal Bathini, MD and Anita Rajasekhar, MD.

CMS Open Payments shows 1 general payment to Dr. Mathew from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $35.

Dr. Mathew graduated from Ross University School of Medicine in 2013.

Dr. Mathew is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.